Bone morphogenetic protein 9 protects against neonatal hyperoxia-induced impairment of lung development, inflammation and fibrosis

Xueyu Chen,Mar Orriols,El Houari Laghmani,Annemarie M. Hoogeboom,Anne C. B. Hogen-Esch,Pieter S. Hiemstra,Gert Folkerts,Marie-José Goumans,Peter ten Dijke,Nicholas W. Morrell,Gerry T. M. Wagenaar,Frans J. Walther
DOI: https://doi.org/10.1183/1393003.congress-2017.PA2082
IF: 24.3
2017-01-01
European Respiratory Journal
Abstract:Bone morphogenetic protein 9 (BMP9) may be a novel therapeutic option for bronchopulmonary dysplasia (BPD) by restoring alveolar development and preventing lung inflammation, and pulmonary arterial hypertension, but its role in BPD is unknown. Therefore, we determined the cardiopulmonary effects of BMP9 (2.5 µg/kg daily) in neonatal Wistar rats with BPD, exposed to 100% oxygen for 10 days. We investigated differential mRNA expression of the BMP9 receptor complex: activin receptor-like kinase 1 (ALK1), BMP receptor type 2 (BMPR2) and Endoglin and protein expression of the ALK1 downstream target transmembrane protein 100 (TMEM100). Parameters investigated included survival and lung and heart histopathology, vascular leakage, cytokine expression, and collagen and fibrin deposition. The effect of BMP9 (5 ng/ml) on inflammatory cytokine production was studied in endothelial cell cultures. ALK1, ALK2, BMPRII, TMEM100 and Endoglin were differentially expressed in experimental BPD. TMEM100 was expressed in the wall of blood vessels, showing an elastin-like expression pattern in arterioles. BMP9 treatment of experimental BPD improved alveolarization and reduced lung septal thickness, inflammation and collagen III deposition, but did not attenuate vascular remodelling and right ventricular hypertrophy. The anti-inflammatory effect of BMP9 was confirmed in vitro. Stimulation of human endothelial cell cultures with BMP9 reduced their oxidative stress-induced pro-inflammatory cytokine response. BMP9 attenuates alveolar enlargement, lung inflammation and fibrosis in neonatal rats with severe BPD, demonstrating its therapeutic potential for premature infants with BPD.
What problem does this paper attempt to address?